DTC
ABBV icon

Davidson Trust Company’s AbbVie ABBV Stock Holding History

Davidson Trust Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.53M Sell
33,886
-2,464
-7% -$530K 3.33% 3
2026
Q1 		$7.91M Sell
36,350
-2,612
-7% -$579K 3.41% 3
2025
Q4 		$8.9M Buy
38,962
+314
+0.8% +$71.5K 3.71% 3
2025
Q3 		$8.95M Sell
38,648
-942
-2% -$192K 3.69% 3
2025
Q2 		$7.35M Sell
39,590
-2,174
-5% -$404K 3.39% 3
2025
Q1 		$8.75M Buy
41,764
+421
+1% +$81.8K 4.17% 3
2024
Q4 		$7.35M Sell
41,343
-60
-0.1% -$11K 3.78% 3
2024
Q3 		$8.18M Buy
41,403
+27,944
+208% +$5.22M 4.2% 3
2024
Q2 		$2.31M Sell
13,459
-29,787
-69% -$4.93M 1.59% 13
2024
Q1 		$7.88M Hold
43,246
– – 4.59% 3
2023
Q4 		$6.7M Buy
43,246
+107
+0.2% +$15.6K 4.32% 3
2023
Q3 		$6.43M Hold
43,139
– – 4.77% 3
2023
Q2 		$5.81M Buy
43,139
+125
+0.3% +$18.3K 4.2% 3
2023
Q1 		$6.86M Buy
43,014
+3
+0% +$459 5.28% 3
2022
Q4 		$6.95M Sell
43,011
-52
-0.1% -$7.97K 6.14% 2
2022
Q3 		$5.78M Hold
43,063
– – 5.55% 3
2022
Q2 		$6.6M Sell
43,063
-303
-0.7% -$46.3K 5.88% 3
2022
Q1 		$7.03M Sell
43,366
-300
-0.7% -$43.6K 5.23% 3
2021
Q4 		$5.91M Sell
43,666
-7,104
-14% -$839K 4.06% 3
2021
Q3 		$5.48M Sell
50,770
-11,545
-19% -$1.32M 4.18% 3
2021
Q2 		$7.02M Sell
62,315
-45
-0.1% -$5.07K 5.47% 3
2021
Q1 		$6.75M Buy
62,360
+40
+0.1% +$4.28K 5.67% 3
2020
Q4 		$6.68M Sell
62,320
-600
-1% -$57.7K 5.74% 3
2020
Q3 		$5.51M Sell
62,920
-55
-0.1% -$5.18K 5.01% 4
2020
Q2 		$6.18M Hold
62,975
– – 6.01% 2
2020
Q1 		$4.8M Sell
62,975
-170
-0.3% -$14.5K 5.92% 2
2019
Q4 		$5.59M Buy
+63,145
New +$5.24M 5.64% 1

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Davidson Trust Company's ABBV Position: Q2 2026 in Review

Davidson Trust Company reduced its AbbVie (ABBV) stake by 6.8% in Q2 2026, selling an estimated $530K and leaving 33,886 shares worth $8.53M. The position accounts for 3.33% of the portfolio, ranked #3.

Davidson Trust Company first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $8.95M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Davidson Trust Company held 33,886 shares of AbbVie worth $8.53M as of Q2 2026.
  • Davidson Trust Company sold 2,464 AbbVie shares in Q2 2026, an estimated $530K.
  • AbbVie made up 3.33% of Davidson Trust Company's portfolio in Q2 2026, its #3 holding.
  • Davidson Trust Company first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Davidson Trust Company's AbbVie position peaked at $8.95M in Q3 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Davidson Trust Company's 13F filing for Q2 2026, filed 29 Jul 2026.